Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. - Wikidata - wikimedia - TriplyDB

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

http://www.wikidata.org/entity/Q36932173

about

Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes Type 1 diabetes through the life span: a position statement of the American Diabetes Association Environmental risk factors for type 1 diabetes A rapid lateral flow immunoassay for the detection of tyrosine phosphatase-like protein IA-2 autoantibodies in human serum Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study Type 1 diabetes mellitus.Type 1 diabetes: a disease of developmental origins.Genetics and its potential to improve type 1 diabetes care.A 3D map of the islet routes throughout the healthy human pancreas.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Risk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function.Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes.Early prediction of autoimmune (type 1) diabetes.Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity.Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes.A complex role of herpes viruses in the disease process of multiple sclerosis.Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definition Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.Role of viruses and other microbes in the pathogenesis of type 1 diabetes.Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients.The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.Type 1 diabetes: A predictable disease.Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.Reliable diagnosis of murine type 1 diabetes using a panel of autoantigens and "antigen surrogates" mounted onto a liquid array.Thrombophilia Associated with Anti-DFS70 Autoantibodies.

P2860

Q21260349-90BEDBBF-63FE-4E12-8FE9-1445969DF53B Q26748984-47705022-1AD0-46DB-9DA4-E9C57376DB4A Q26777399-E777A14E-591D-4A39-A4F6-A4DD7D31D994 Q26783728-63E60F83-AEFF-4818-ACCC-D93635FAF8FC Q26800973-D94A5A92-85A1-4F7A-A219-A969A1ED721D Q27346599-493FDD81-E424-49B0-86CD-70D8435079AF Q27687598-ABAD82C9-54DC-48BF-8317-9D0413C3B89F Q28081034-22A8F70D-33D9-44AD-A5C1-E1C3BDAB77BC Q28084487-E9678681-3076-4913-9469-8BDCDF8D94A4 Q28242092-072748E7-7844-4C16-B71D-3A03E4F5764C Q28276366-61A56A6E-DDF9-42DB-8ECD-97BCB4AA3514 Q28390646-41DB94C1-A41D-4EE8-A34D-D366DF691CFD Q28602447-68E14AB5-D6C1-4F04-B43E-6BFA9999F675 Q30235021-5A2FE196-5D04-4E80-82E1-E0CA2BCFEB2B Q30248490-B4577B8B-2944-46B8-AD7F-78EFCDF93881 Q30252400-92F5CFCF-E6D0-4C57-969E-542379673373 Q30666066-8736CC22-BA76-40BB-BC22-305ED05DDBB3 Q30732418-034234FE-7B26-43F9-940F-4EE31B31308C Q33729769-70CEDA61-8A0F-4695-8743-E988C9D6D8EC Q33789317-30921F85-F410-4143-9D63-5A52688FEB9B Q33789346-E285EB6F-DE92-4234-ADCD-A8FF088F2B2D Q33793829-E58D3C65-6D6D-4A03-B0DE-EB205712C812 Q33854613-D5D965DA-D747-43EE-B89B-D2511479D232 Q33916508-968288E5-4EAB-4D1C-9860-6C4F924B7FB9 Q34065354-3F7B2455-E6A7-4592-A820-199441FE1754 Q34078589-643EB25B-1094-4AC4-8C69-34BDC60D9C78 Q34181376-72475C49-FD45-48CB-BE6C-1C00BD09391C Q34477816-6387E1A9-A15D-4169-A720-D0141D1B1DF6 Q34604619-F377C25F-9918-47B9-B00D-487CDBF7516B Q35064081-141DD39B-0DDE-4801-98AD-5969BC1DC61B Q35108159-9BE18358-C06E-4857-B322-7FA5707E4432 Q35115373-3CAFD646-BE54-4195-A49A-608AF533F1AA Q35128879-1CA5FFB5-DBF1-439A-934B-B92D47C921E5 Q35371094-60C8AE7C-1916-4588-BA9C-0DF9D6F72318 Q35378628-57E8DDE0-CDA2-41B7-89D7-B4CC5AC25248 Q35437721-3EECED15-7447-44A9-A6D6-2B9FDF6D66FD Q35531906-178E74E5-10BE-4B2B-AB18-2E810AC7CC0A Q35557877-538FCAE9-1252-45E8-AB62-551A4BF601CD Q35782179-08B09728-4E79-417A-9110-CCAA152A1690 Q35784744-D51CC045-6FAC-49F4-83BA-EF007081F9BB

P2860

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

http://www.wikidata.org/entity/Q36932173

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Seroconversion to multiple isl ...... ssion to diabetes in children.

@en

type

label

Seroconversion to multiple isl ...... ssion to diabetes in children.

@en

prefLabel

Seroconversion to multiple isl ...... ssion to diabetes in children.

@en

P1433

Q36932173-0382D35E-9278-45C4-9CC2-FFA6017BB6A2

P1476

Q36932173-2F2DE9C0-DE26-40A5-AFE9-CE92403DF045

P2093

Q36932173-2EB0F791-7EB4-430B-AE36-89D05A30D6CA

Q36932173-5AB6A7EE-B090-48B6-9950-25E8ECD6C570

Q36932173-6C6A2806-52AF-412A-AC68-829153A0ADA8

Q36932173-83F29EEC-641C-4665-AF36-D96009C9BE96

Q36932173-D314FF5C-ED61-4BA3-94C4-1C4D84B4462C

Q36932173-EE11DB2B-8D88-4672-A74D-74D187E74DDA

Q36932173-F294D2C6-0186-49FB-9827-CB4886D420A8

P2860

Q36932173-1E26B9C9-10F0-4B6F-8F9F-8B2B5BE27EC8

Q36932173-264492D5-172D-4AC6-838B-9772D9DA8FEF

Q36932173-4AC341D7-48EA-4ECD-A068-2FD153D1D211

Q36932173-533DC262-0FE7-452B-B81D-3DFAC2C88D70

Q36932173-7C6BB6A7-E355-4930-A438-48529CA20089

Q36932173-81D81F8C-F920-4B09-894B-6F65451750B3

Q36932173-834B62D9-8662-4549-9B2F-F375889BD4DF

Q36932173-902BBE5F-E993-4935-8F68-56F3CFFE12D4

Q36932173-94461821-55F3-47CD-984B-3B61F9BEDC7D

Q36932173-A378EEBF-7FD5-498C-BA48-B3FF4B7DD654

P304

Q36932173-B682623E-1549-4480-B1CC-6FA532E1342F

P31

Q36932173-3B957F7B-0355-48FC-9EBF-D1DBECA0947B

P356

Q36932173-2FDB2C87-6966-4920-ABFB-28E0E6550865

P407

Q36932173-0E9B702C-DF59-4FF3-9D34-B40B8A27B639

P433

Q36932173-9B3915A3-951C-40AF-A0E2-5C2F2FB88AC9

P478

Q36932173-5B9EA41E-58E3-4716-8479-1CDAF40A6986

P50

Q36932173-5C656886-212C-4895-A62F-94BCB164F03C

Q36932173-A0EC11AF-B4D6-4071-AC93-9282F8DFA5DF

Q36932173-C120F378-CD8B-43DF-81BF-9BB5345B3471

Q36932173-CD09B292-A6C9-4550-85CB-92EA2DFBED88

Q36932173-DD429F5B-280C-40B2-9C0C-1B758C85F47A

P577

Q36932173-A8281573-BC0C-4C44-8468-0CF9D34BC5D2

P5875

Q36932173-7845D7E9-2694-429E-A91D-D417E6DB96F6

P698

Q36932173-682DBD27-38B1-4B2D-8199-CEEB32D05C3A

P921

Q36932173-06C2E90A-C17C-4B62-91C9-D1801408AC2F

Q36932173-EF32898C-7F1C-4ED7-BEF9-276D87BF9FFB

P932

Q36932173-57015DC9-76F5-496B-B582-8231E79C658E

P356

P1433

Journal of the American Medical Association

P1476

Seroconversion to multiple isl ...... ssion to diabetes in children.

@en

P2093

Andrea Steck

http://www.w3.org/2001/XMLSchema#string

Anette G Ziegler

http://www.w3.org/2001/XMLSchema#string

Christiane Winkler

http://www.w3.org/2001/XMLSchema#string

George S Eisenbarth

http://www.w3.org/2001/XMLSchema#string

Johanna Lempainen

http://www.w3.org/2001/XMLSchema#string

Olli Simell

http://www.w3.org/2001/XMLSchema#string

Tuula Simell

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of type 1 diabetes in the general population.

Type I diabetes mellitus. A chronic autoimmune disease.

Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study

Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies

The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review.

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes.

Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

P304

2473-2479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2013.6285

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239948046

http://www.w3.org/2001/XMLSchema#string

P698

23780460

http://www.w3.org/2001/XMLSchema#string

P921

P932

4878912

http://www.w3.org/2001/XMLSchema#string